Skip to main content
Stanley Lipkowitz, MD, Oncology, Bethesda, MD

StanleyLipkowitzMD

Oncology • Bethesda, MD

Professor, Medicine, Uniformed Services Hebert SOM

Join to view full profile

Dr. Lipkowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lipkowitz's full profile

Already have an account?

  • Office

    Women's Malignancies Branch, National Cancer Institute, NIH
    Building 10, Room 4B54, 10 Center Drive
    Bethesda, MD 20892
    Phone+1 240-760-6129
    Fax+1 240-541-4547

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1984 - 1987
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1984

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Behind the Study: How ONC201 Kills Breast Cancer Cells
    Behind the Study: How ONC201 Kills Breast Cancer CellsApril 22nd, 2022
  • Panel Tells FDA to Keep Atezolizumab Approval in TNBC
    Panel Tells FDA to Keep Atezolizumab Approval in TNBCApril 28th, 2021
  • ONC201 Kills Breast Cancer Cells in Vitro by Targeting Mitochondria
    ONC201 Kills Breast Cancer Cells in Vitro by Targeting MitochondriaMay 9th, 2018
  • Join now to see all

Grant Support

  • Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2010–2011
  • CBL Proteins As Regulators Of Tyrosine Kinase SignalingNational Cancer Institute2010–2011
  • Trail-Induced Cell Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci2009
  • Identification Of Molecular Targets In Triple-Negative Breast CancerDivision Of Basic Sciences - Nci2009
  • CBL Proteins As Regulators Of Tyrosine Kinase SignalingDivision Of Basic Sciences - Nci2009
  • Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2008
  • Identification Of Molecular Targets In Triple-Negative Breast CancerNational Cancer Institute2008
  • Signal Transduction In Epithelial Cancer CellsNational Cancer Institute2007
  • Signal Transduction In Epithelial Cancer CellsDivision Of Clinical Sciences - Nci2006
  • Molecular Control Of Growth, Differentiation, And DeathDivision Of Clinical Sciences - Nci2001–2005
  • Molecular Control Of Growth, Differentiation, And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1999–2000
  • Molecular Control Of Growth, Differentiation And Death In Breast Cancer CellsDivision Of Clinical Sciences - Nci1996–1998

Dr. Stanley Lipkowitz, Dr. Stanley Lipkowitz, MD, Dr. S Lipkowitz